logo

HROW

Harrow·NASDAQ
--
--(--)
--
--(--)
4.17 / 10
Netural

Fundamentally, HROW rates 4.2/10, indicating modest strength. Positive factors include cost‑of‑sales (24.98%) and current‑liabilities ratio, while long‑term debt to working capital and revenue‑MV are weak. Overall rating is neutral, suggesting guarded outlook.

Fundamental(4.17)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.94
Score1/3
Weight21.31%
1M Return4.09%
Total operating revenue (YoY growth rate %)
Value36.41
Score2/3
Weight0.59%
1M Return0.13%
Inventory turnover ratio
Value5.61
Score2/3
Weight-4.89%
1M Return-1.18%
Current liabilities / Total liabilities (%)
Value27.72
Score2/3
Weight1.66%
1M Return0.36%
PB-ROE
Value3.31
Score2/3
Weight40.02%
1M Return7.29%
Long-term debt to working capital ratio (%)
Value2.17
Score0/3
Weight-18.64%
1M Return-4.75%
Interest coverage ratio (EBIT / Interest expense) (%)
Value0.94
Score2/3
Weight-4.97%
1M Return-1.17%
Operating revenue (YoY growth rate %)
Value36.90
Score2/3
Weight0.24%
1M Return0.05%
Cost of sales ratio (%)
Value24.98
Score3/3
Weight1.24%
1M Return0.26%
Asset-MV
Value-0.55
Score2/3
Weight63.45%
1M Return11.12%
Is HROW undervalued or overvalued?
  • HROW scores 4.17/10 on fundamentals and holds a Fair valuation at present. Backed by its -8.47% ROE, -1.89% net margin, -255.80 P/E ratio, 25.24 P/B ratio, and 71.43% earnings growth, these metrics solidify its Netural investment rating.